Dhs _primary care formulary_list september 12 2011.xlsx
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information
Acetaminophen/ Butalbital/ Caffeine (Fioricet)
Acetaminophen/ Hydrocodone 325mg/10mg (Norco) Arthritis & Pain
Acetaminophen/ Oxycodone 325/5mg (Percocet)
Acetaminophen/Codeine 300mg/30mg (Tylenol #3)
tabletAcetaminophen/Hydrocodone 500mg/5mg (Vicodin)
Amphetamine/ Dextroamphetamine Salts 5mg tab
Antipyrine/Benzocaine (Auralgan) otic solution
Aspirin 325mg (with or w/o enteric coating)
Aspirin 81mg (with or w/o enteric coating)
Connection to Care Atorvastatin 80mg tablet Cholesterol 1 NO Pfizer
Bacitracin, neomycin, polymyxin B ointment/cream
Bismuth Subsalicylate (Pepto-Bismol) 262mg/15mL
Bismuth Subsalicylate (Pepto-Bismol) 262mg tablet
Blood Glucose Meter Diabetes
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information
Calcium Carbonate 600mg +Vitamin D 400 Units
Carbamide Peroxide (Debrox) 6.5% Otic drop
Chlorhexidine Gluconate 0.12% oral solution
BMS Patient Assistance Clopidogrel 75mg tablet Heart Health & Blood Pressure 1 YES Foundation
Colchicine/ probenecid 0.5mg/500mg tablet
Abbott Patient Divalproex ER 250mg tablet Anticonvulsant 3 YES Assistance Foundation Abbott Patient Divalproex ER 500mg tablet Anticonvulsant 3 YES Assistance Foundation 1 YES
Ergocalciferol 50,000 International Units
Estrogen conjugated 0.3mg tablet Women's Health Pfizer 1 NO
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information Estrogen conjugated 0.625mg tablet Women's Health Pfizer 1 NO
Estrogen conjugated 0.625mg/gm vaginal cream
Wyeth Pharmaceutical Estrogen conjugated/Medroxyprogesterone Women's Health Patient Assistance 0.3/1.5mg tablet (Prempro) Foundation 1 NO Wyeth Pharmaceutical Estrogen conjugated/Medroxyprogesterone Women's Health Patient Assistance 0.625/2.5mg tablet (Prempro) Foundation 1 NO Wyeth Pharmaceutical Estrogen conjugated/Medroxyprogesterone Women's Health Patient Assistance 1 NO 0.625/5mg tablet Foundation Merck Patient Ezetimibe 10mg tablet Cholesterol 2 NO Assistance Program Merck Patient Ezetimibe/Simvastatin 10/20mg tablet Cholesterol 2 NO Assistance Program Merck Patient Ezetimibe/Simvastatin 10/40mg tablet Cholesterol 2 NO Assistance Program Abbott Patient Fenofibrate 145mg (Tricor) Cholesterol Assistance Foundation 3 YES Abbott Patient Fenofibrate 48mg (Tricor) Cholesterol Assistance Foundation 3 YES GlaxoSmithKline Bridges Fluticasone 50mcg nasal spray Allergies & Cold and Flu 1 NO to Access
Guaifenesin/ Dextromethorphan 100mg-10mg/5mL
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information
Hydrocortisone 2.5% Rectal Cream (Proctozone HC) Other Medical Conditions
Sanofi-Aventis U.S. Insulin glargine 100units/ml vial Diabetes 10mL Patient Assistance 1 YES Program
Insulin NPH/Regular 70/30 100units/ml vial
Boehringer Ingelheim Ipratropium HFA 17mcg inhaler Asthma/COPD 12.9gm 1 YES Cares Foundation, Inc. GlaxoSmithKline Bridges Lamotrigine 100mg tablet Anticonvulsant 1 NO to Access GlaxoSmithKline Bridges Lamotrigine 25mg tablet Anticonvulsant 1 NO to Access Diabetes
Magnesia) oral suspensionMagnesium hydroxide/ aluminum hydroxide/
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information Merck Patient Mometasone/Formoterol (Dulera) 100mcg/5mcg Asthma/COPD 13Gm 2 YES Assistance Program Merck Patient Mometasone/Formoterol (Dulera) 200mcg/5mcg Asthma/COPD 13Gm 2 YES Assistance Program Merck Patient Montelukast 10mg tablet Asthma/COPD 2 NO Assistance Program
(MS Contin) 60mgMorphine Sulfate Extended-Release
(MS Contin) 15mgMorphine Sulfate Extended-Release
(MS Contin) 30mg Naphazoline HCl 0.025%/ Pheniramine Maleate
Niacin-controlled released (Slo Niacin) 500mg tablet
Nystatin/Triamcinolone cream/ointment (Mycolog II)
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information Takeda Pharmaceuticals Pioglitazone 15mg tablet Diabetes America Patient 1 YES Assistance Program
Polymyxin Sulfate/TMP (Polytrim) ophthalmic solution Glaucoma & Eye Care
Merck Patient Rizatriptan 10mg CNS Agents/ Sedative Hypnotic 2 YES Assistance Program
Sulfacetamide Sodium 10% ophthalmic solution
Tobramycin/ Dexamethasone ophthalmic drop
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
DHS PRIMARY CARE FORMULARY‐ NOV 2011 ‐ BY DRUG NAME Bolded and italicized denote Patient Assistance Program (PAP) availability Additional Medication Therapeutic PAP Availability Information
Triamterene/HCTZ 37.5/25mg capsule/tablet
PAP Legend: 1=Very Accessible, no SSN required 2=Accessible requires SSN
3=Less Accessible, requires SSN and additional information
• Introduction• Unlicensed medicines vs ‘off-label’ prescribing• Legislation• Legal responsibility• Professional guidance• Risks and risk management• Take-home points• Questions• A patient brings a note to your practice from a paediatric cardiologist in which you are asked to take over the prescribing of an combination product containing hydrochlorothiaizde and spiron
PHYTOTHERAPY RESEARCHPhytother. Res. (2012)Published online in Wiley Online Library(wileyonlinelibrary.com) DOI: 10.1002/ptr.4696Improving BPH symptoms and sexualdysfunctions with a saw palmetto preparation?Results from a pilot trialAndreas Suter,1,4* Reinhard Saller,2 Eugen Riedi3 and Michael Heinrich41Medical Department, A. Vogel Bioforce AG, Roggwil, Switzerland2Institute of Natural Medicine,